Satoshi Ikegame
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Satoshi Ikegame has a total of 172 co-authors. Here are the top co-authors by number of shared publications:
- Benhur Lee
Department of Microbiology, Icahn School of Medicine at Mount Sinai, New York, NY 10029, USA
11 shared publications Isamu Okamoto
7 shared publications- Christian S. Stevens
Department of Microbiology, Icahn School of Medicine at Mount Sinai
6 shared publications - Kasopefoluwa Y. Oguntuyo
Icahn School of Medicine at Mount Sinai
5 shared publications - Jeremy Phillip Kamil
Department of Microbiology and Immunology, Louisiana State University Health Sciences Center
4 shared publications - Shreyas Kowdle
Department of Microbiology, Icahn School of Medicine at Mount Sinai
4 shared publications
Latest Publications
- Open Access
- 1 August 2026
- Published by Elsevier in Allergology International
Early versus delayed dupilumab differentially restores IL-13–induced airway barrier dysfunction
- 1 August 2026
- Published by Elsevier in Allergology International
Open AccessEarly versus delayed dupilumab differentially restores IL-13–induced airway barrier dysfunction
- Open Access
- 1 February 2026
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 65 (3) , 396-403
The Evaluation of the Diagnostic Yield and Complications Associated with Bronchoscopy via Endobronchial Ultrasound with a Guide Sheath
Background and objective Endobronchial ultrasound with a guide sheath (EBUS-GS) is used to accurately position a bronchoscope in lung lesions using a guide sheath. Previous studies have focused on diagnostic success as the endpoint. The achievement of 'within' defined as reaching the lesion, is considered crucial in EBUS-GS procedures. This study investigated cases wherein 'within' is likely to be achieved and cases that can be diagnosed after achieving 'within'. Methods This retrospective study evaluated 258 bronchoscopic examinations using EBUS-GS. We analyzed the relationship between patient background, lesion size and characteristics, achieving 'within', definitive diagnosis after achieving 'within', and complications. Results and Conclusion A multivariate analysis revealed that lesion size ≥20 mm (odds ratio 12, 95% confidence interval [CI]: 6.0-21, p<0.01) and lesions with solid components (odds ratio 13, 95% CI: 1.3-120, p=0.03) were associated with achieving 'within'. For cancer cases, lesion size ≥20 mm was associated with a higher diagnostic rate following achieving 'within' than smaller lesions (odds ratio 4.23, 95% CI: 1.38-12.9, p=0.01). The occurrence of complications was linked to lesion size ≥20 mm (odds ratio 2.7, 95% CI: 1.02-6.9, p=0.045). The factors associated with 'within'-achieving bronchoscopy via EBUS-GS included lesion size ≥20 mm and solid components. Larger lesions were associated with a definitive diagnosis. Lesion size was a determinant in improving diagnostic rates, both for achieving within and for successful diagnosis after achieving 'within'.
- 1 February 2026
- Published by Japanese Society of Internal Medicine in Internal Medicine
- Vol. 65 (3) , 396-403
Open AccessThe Evaluation of the Diagnostic Yield and Complications Associated with Bronchoscopy via Endobronchial Ultrasound with a Guide Sheath
Background and objective Endobronchial ultrasound with a guide sheath (EBUS-GS) is used to accurately position a bronchoscope in lung lesions using a guide sheath. Previous studies have focused on diagnostic success as the endpoint. The achievement of 'within' defined as reaching the lesion, is considered crucial in EBUS-GS procedures. This study investigated cases wherein 'within' is likely to be achieved and cases that can be diagnosed after achieving 'within'. Methods This retrospective study evaluated 258 bronchoscopic examinations using EBUS-GS. We analyzed the relationship between patient background, lesion size and characteristics, achieving 'within', definitive diagnosis after achieving 'within', and complications. Results and Conclusion A multivariate analysis revealed that lesion size ≥20 mm (odds ratio 12, 95% confidence interval [CI]: 6.0-21, p<0.01) and lesions with solid components (odds ratio 13, 95% CI: 1.3-120, p=0.03) were associated with achieving 'within'. For cancer cases, lesion size ≥20 mm was associated with a higher diagnostic rate following achieving 'within' than smaller lesions (odds ratio 4.23, 95% CI: 1.38-12.9, p=0.01). The occurrence of complications was linked to lesion size ≥20 mm (odds ratio 2.7, 95% CI: 1.02-6.9, p=0.045). The factors associated with 'within'-achieving bronchoscopy via EBUS-GS included lesion size ≥20 mm and solid components. Larger lesions were associated with a definitive diagnosis. Lesion size was a determinant in improving diagnostic rates, both for achieving within and for successful diagnosis after achieving 'within'.
- Open Access
- 7 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (2) , 316
Immunophenotyping of T Cells in Lung Malignancies and Cryptogenic Organizing Pneumonia
Background: Lung malignancies, including cancerous lymphangitis and lymphomas, can mimic interstitial lung diseases like cryptogenic organizing pneumonia (COP) on imaging, leading to diagnostic delays. We aimed to identify potential biomarkers to distinguish between these conditions. Methods: We analyzed bronchoalveolar lavage fluid from 8 patients (4 COP, mean age 59.8 ± 13.5 years; 4 lung malignancies including 2 cancerous lymphangitis, 1 MALT lymphoma, and 1 diffuse large B cell lymphoma, mean age 67.8 ± 4.5 years) using mass cytometry with 35 T cell markers. Data were analyzed using principal component analysis (PCA) and unsupervised Citrus clustering. Results: PCA of T cell marker intensities effectively separated the two groups, with IL-2Rα, PD-L2, CD45RA, CD44, and OX40 being the top discriminating markers. Citrus analysis showed a significant increase in the CD16+ CD4+ and CD16+ CD8+ T cell populations in the COP group compared to lung malignancies. Conclusions: Our findings reveal distinct T cell immunophenotypes in COP versus lung malignancies, particularly increased CD16+ T cells in COP, which could serve as potential diagnostic biomarkers.
- 7 January 2025
- Published by MDPI AG in Journal of Clinical Medicine
- Vol. 14 (2) , 316
Open AccessImmunophenotyping of T Cells in Lung Malignancies and Cryptogenic Organizing Pneumonia
Background: Lung malignancies, including cancerous lymphangitis and lymphomas, can mimic interstitial lung diseases like cryptogenic organizing pneumonia (COP) on imaging, leading to diagnostic delays. We aimed to identify potential biomarkers to distinguish between these conditions. Methods: We analyzed bronchoalveolar lavage fluid from 8 patients (4 COP, mean age 59.8 ± 13.5 years; 4 lung malignancies including 2 cancerous lymphangitis, 1 MALT lymphoma, and 1 diffuse large B cell lymphoma, mean age 67.8 ± 4.5 years) using mass cytometry with 35 T cell markers. Data were analyzed using principal component analysis (PCA) and unsupervised Citrus clustering. Results: PCA of T cell marker intensities effectively separated the two groups, with IL-2Rα, PD-L2, CD45RA, CD44, and OX40 being the top discriminating markers. Citrus analysis showed a significant increase in the CD16+ CD4+ and CD16+ CD8+ T cell populations in the COP group compared to lung malignancies. Conclusions: Our findings reveal distinct T cell immunophenotypes in COP versus lung malignancies, particularly increased CD16+ T cells in COP, which could serve as potential diagnostic biomarkers.
- Open Access
- 31 May 2024
- Published by Springer Nature in Cureus
- Vol. 16 (5) , e61470
The Utility and Limitations of Universal Polymerase Chain Reaction Screening for SARS-CoV-2 During Hospital Admission
Objective: Universal polymerase chain reaction (PCR) screening for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on hospital admission is an effective approach to preventing coronavirus disease 2019 (COVID-19) outbreaks in medical facilities. However, false-positive test results due to a recent infection are a concern. We investigated the usefulness and limitations of universal PCR screening for SARS-CoV-2 on hospital admission in a real-world setting. Methods: We retrospectively analyzed 1320 attempted hospital admissions for 775 patients at the Department of Respiratory Medicine, Kyushu University Hospital, between January 1, 2022, and May 2, 2023. Results: Thirty-nine out of 1201 PCR tests (3.2%) yielded a positive result, with 22 of these results being considered false positives on the basis of a recent infection. We found that 39% of cases showed a positive PCR result between 31 and 60 days after the onset of COVID-19, although the threshold cycle (Ct) for target 1 (ORF1ab gene) of the Cobas SARS-CoV-2 test (Roche Diagnostics, Basel, Switzerland) was >30 in most instances. Conclusion: Hospital admission based on the results of PCR screening for SARS-CoV-2 should take into account not only PCR positivity but also the Ct value and recent COVID-19 history.
- 31 May 2024
- Published by Springer Nature in Cureus
- Vol. 16 (5) , e61470
Open AccessThe Utility and Limitations of Universal Polymerase Chain Reaction Screening for SARS-CoV-2 During Hospital Admission
Objective: Universal polymerase chain reaction (PCR) screening for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) on hospital admission is an effective approach to preventing coronavirus disease 2019 (COVID-19) outbreaks in medical facilities. However, false-positive test results due to a recent infection are a concern. We investigated the usefulness and limitations of universal PCR screening for SARS-CoV-2 on hospital admission in a real-world setting. Methods: We retrospectively analyzed 1320 attempted hospital admissions for 775 patients at the Department of Respiratory Medicine, Kyushu University Hospital, between January 1, 2022, and May 2, 2023. Results: Thirty-nine out of 1201 PCR tests (3.2%) yielded a positive result, with 22 of these results being considered false positives on the basis of a recent infection. We found that 39% of cases showed a positive PCR result between 31 and 60 days after the onset of COVID-19, although the threshold cycle (Ct) for target 1 (ORF1ab gene) of the Cobas SARS-CoV-2 test (Roche Diagnostics, Basel, Switzerland) was >30 in most instances. Conclusion: Hospital admission based on the results of PCR screening for SARS-CoV-2 should take into account not only PCR positivity but also the Ct value and recent COVID-19 history.
- Open Access
- 29 November 2023
- Published by The Japan Society for Respiratory Endoscopy in Respiratory Endoscopy
- Vol. 1 (2) , 78-82
Successful Treatment against Mediastinal Methicillin-resistant Staphylococcus aureus Infection after an Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Procedure
The case involves a 57-year-old man with a history of laryngeal and lung cancers. He underwent a laryngectomy and right upper lobectomy and developed tracheal methicillin-resistant Staphylococcus aureus (MRSA) colonization. He also underwent endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) to diagnose right mediastinal lymph node adenopathy. His recovery was complicated by a mediastinal infection caused by MRSA five days post-procedure. Combining triple antibiotics comprising MEPM, DAP, and VCM for three weeks gradually improved the mediastinal infection. To our knowledge, this is the first report of mediastinal infection caused by MRSA after EBUS-TBNA. Our successful treatment of EBUS-TBNA-related infectious complications gives us information regarding rare complications management caused by EBUS-TBNA.
- 29 November 2023
- Published by The Japan Society for Respiratory Endoscopy in Respiratory Endoscopy
- Vol. 1 (2) , 78-82
Open AccessSuccessful Treatment against Mediastinal Methicillin-resistant Staphylococcus aureus Infection after an Endobronchial Ultrasound-guided Transbronchial Needle Aspiration Procedure
The case involves a 57-year-old man with a history of laryngeal and lung cancers. He underwent a laryngectomy and right upper lobectomy and developed tracheal methicillin-resistant Staphylococcus aureus (MRSA) colonization. He also underwent endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) to diagnose right mediastinal lymph node adenopathy. His recovery was complicated by a mediastinal infection caused by MRSA five days post-procedure. Combining triple antibiotics comprising MEPM, DAP, and VCM for three weeks gradually improved the mediastinal infection. To our knowledge, this is the first report of mediastinal infection caused by MRSA after EBUS-TBNA. Our successful treatment of EBUS-TBNA-related infectious complications gives us information regarding rare complications management caused by EBUS-TBNA.
- Open Access
- 21 September 2023
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 9 (5)
Altered macrophage phenotypes in a case of autoimmune pulmonary alveolar proteinosis
Pulmonary alveolar proteinosis (PAP) is an ultra-rare disease characterised by abnormal accumulation of surfactant components in the alveoli [1]. The majority of cases are of an autoimmune nature (previously named primary or idiopathic) and are linked to the presence of an autoantibody targeting granulocyte–macrophage colony-stimulating factor (GM-CSF) [1]. This anti-GM-CSF antibody impedes the ability of alveolar macrophages to remove pulmonary surfactant. As a consequence, a significant proportion of patients experience progressive respiratory failure and immune deficiency [1]. While considerable progress has been made in understanding the pathophysiology of PAP over the past two decades, there has yet to be an in-depth analysis of macrophage phenotypes in human lungs with PAP. Our study reports on a case of PAP and presents a novel approach to analysing macrophage phenotypes in this condition using mass cytometry.
- 21 September 2023
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 9 (5)
Open AccessAltered macrophage phenotypes in a case of autoimmune pulmonary alveolar proteinosis
Pulmonary alveolar proteinosis (PAP) is an ultra-rare disease characterised by abnormal accumulation of surfactant components in the alveoli [1]. The majority of cases are of an autoimmune nature (previously named primary or idiopathic) and are linked to the presence of an autoantibody targeting granulocyte–macrophage colony-stimulating factor (GM-CSF) [1]. This anti-GM-CSF antibody impedes the ability of alveolar macrophages to remove pulmonary surfactant. As a consequence, a significant proportion of patients experience progressive respiratory failure and immune deficiency [1]. While considerable progress has been made in understanding the pathophysiology of PAP over the past two decades, there has yet to be an in-depth analysis of macrophage phenotypes in human lungs with PAP. Our study reports on a case of PAP and presents a novel approach to analysing macrophage phenotypes in this condition using mass cytometry.
- 31 July 2023
- Published by Springer Nature in Annals of Hematology
- Vol. 102 (10) , 2959-2961
Mass cytometry analysis of B-cell populations in extranodal marginal-zone lymphoma of mucosa-associated lymphoid tissue of the lung
- 31 July 2023
- Published by Springer Nature in Annals of Hematology
- Vol. 102 (10) , 2959-2961
Mass cytometry analysis of B-cell populations in extranodal marginal-zone lymphoma of mucosa-associated lymphoid tissue of the lung
- Open Access
- 13 April 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (2) , e0416222
Respiratory Virus Infections during the COVID-19 Pandemic Revealed by Multiplex PCR Testing in Japan
Influenza virus, RSV, adenovirus, and rhino/enterovirus were the major respiratory viruses before COVID-19 pandemic. Circulating respiratory viruses may have been affected by our strong quarantine policy during the COVID-19 pandemic.
- 13 April 2023
- Published by American Society for Microbiology in Microbiology Spectrum
- Vol. 11 (2) , e0416222
Open AccessRespiratory Virus Infections during the COVID-19 Pandemic Revealed by Multiplex PCR Testing in Japan
Influenza virus, RSV, adenovirus, and rhino/enterovirus were the major respiratory viruses before COVID-19 pandemic. Circulating respiratory viruses may have been affected by our strong quarantine policy during the COVID-19 pandemic.
- Open Access
- 30 March 2023
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 9 (3)
Expansion of ST2-expressing macrophages in a patient with bronchiolitis obliterans syndrome
Bronchiolitis obliterans syndrome (BOS) is a major complication of haematopoietic stem cell transplantation (HSCT), which affects the lungs and has limited treatment options [1]. BOS after HSCT is considered a manifestation of chronic graft-versus-host disease (GVHD). T-cells play a crucial role in its onset [2], while the contribution of myeloid cells has been largely unknown.
- 30 March 2023
- Published by European Respiratory Society (ERS) in ERJ Open Research
- Vol. 9 (3)
Open AccessExpansion of ST2-expressing macrophages in a patient with bronchiolitis obliterans syndrome
Bronchiolitis obliterans syndrome (BOS) is a major complication of haematopoietic stem cell transplantation (HSCT), which affects the lungs and has limited treatment options [1]. BOS after HSCT is considered a manifestation of chronic graft-versus-host disease (GVHD). T-cells play a crucial role in its onset [2], while the contribution of myeloid cells has been largely unknown.
- Open Access
Immunological landscape of human lymphoid explants during measles virus infection
Lymph nodes are the primary site of replication for measles virus (MeV). Here, we modeled MeV infection in human tonsil explants, utilizing a clinical strain of MeV that expresses GFP. We show that MeV replicates efficiently in this tissue as measured by increasing infectious virus production and GFP+ cells (>10% of tonsillar cells by day 8). Using scRNA-Seq, we identified 29 cell populations, all of which were susceptible to MeV. While T cells were the most abundant cell type in the lymphoid explants, B cells were the dominant infected population. Flow cytometry analysis revealed that the preferential infection of B cells was associated with higher CD150 expression. We found that while germinal center B cells were the largest population of infected B cells, there were no differences in susceptibility to MeV among individual B cell subsets. Among CD3+ T cells, infection in both the CD4+ and CD8+ compartments displayed bias towards antigen experienced subsets and away from naive cells, consistent with relative CD150 expression. Differential gene expression analysis revealed that the host response to MeV was dominated by the potent induction of interferon stimulated genes within both T and B cells. These data provide new insights into how MeV infection progresses in lymph nodes, a critical launching point for pathogenesis. Author Summary Measles virus (MeV) is a re-emerging pathogen that has dramatic disease outcomes in children. Immunological amnesia is a dangerous disease outcome that is caused by MeV infection of lymphocytes. Here, we infect human tonsil explants with a GFP-expressing clinical isolate of MeV to assess the immunological events that occur during infection of this critical site. Using single-cell RNA sequencing, we identified 29 distinct populations of tonsillar cells that are susceptible to MeV infection. Further immunophenotyping revealed a preferential infection of B cell lineages compared to T cell lineages, and that among T cells, memory cells are preferential targets of infection compared to naïve counterparts. Taken together, our data thoroughly characterize the infectious and immunological events that shape disease progression in lymph nodes and identify cellular susceptibilities to MeV infection which may be critical in the development of antivirals for MeV. CONFLICTS OF INTEREST The authors have declared that no conflict of interest exists.
Open AccessImmunological landscape of human lymphoid explants during measles virus infection
Lymph nodes are the primary site of replication for measles virus (MeV). Here, we modeled MeV infection in human tonsil explants, utilizing a clinical strain of MeV that expresses GFP. We show that MeV replicates efficiently in this tissue as measured by increasing infectious virus production and GFP+ cells (>10% of tonsillar cells by day 8). Using scRNA-Seq, we identified 29 cell populations, all of which were susceptible to MeV. While T cells were the most abundant cell type in the lymphoid explants, B cells were the dominant infected population. Flow cytometry analysis revealed that the preferential infection of B cells was associated with higher CD150 expression. We found that while germinal center B cells were the largest population of infected B cells, there were no differences in susceptibility to MeV among individual B cell subsets. Among CD3+ T cells, infection in both the CD4+ and CD8+ compartments displayed bias towards antigen experienced subsets and away from naive cells, consistent with relative CD150 expression. Differential gene expression analysis revealed that the host response to MeV was dominated by the potent induction of interferon stimulated genes within both T and B cells. These data provide new insights into how MeV infection progresses in lymph nodes, a critical launching point for pathogenesis. Author Summary Measles virus (MeV) is a re-emerging pathogen that has dramatic disease outcomes in children. Immunological amnesia is a dangerous disease outcome that is caused by MeV infection of lymphocytes. Here, we infect human tonsil explants with a GFP-expressing clinical isolate of MeV to assess the immunological events that occur during infection of this critical site. Using single-cell RNA sequencing, we identified 29 distinct populations of tonsillar cells that are susceptible to MeV infection. Further immunophenotyping revealed a preferential infection of B cell lineages compared to T cell lineages, and that among T cells, memory cells are preferential targets of infection compared to naïve counterparts. Taken together, our data thoroughly characterize the infectious and immunological events that shape disease progression in lymph nodes and identify cellular susceptibilities to MeV infection which may be critical in the development of antivirals for MeV. CONFLICTS OF INTEREST The authors have declared that no conflict of interest exists.